IPOs get back in­to gear with fil­ings from Lian­Bio and Xilio, and Cor­moran­t's SPAC has a deal

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

As the fourth quar­ter gets un­der­way, the biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER